Eur J Heart Fail: Risk of heart failure in patients with type 2 diabetes with ischemic heart disease and end-stage kidney disease

Recently, a study published in the journal European Journal of Heart Failure, a cardiovascular field, looked at assessing the risk of heart failure (HF) in patients with type 2 diabetes (HF) who combined ischemic heart disease (IHD), end-stage renal disease (ESRD) or both, and compared them to T2D patients without IHD and ESRDresearchers identified all new T2D patients with no history of HF between 1998 and 2015 from the National Registry in DenmarkLandmark analysis is used to assess the 5-year absolute risk of HF over several follow-up periods and explain the occurrence of IHD and ESRD prior to HF diagnosisthe study included 285,024 new T2D patientsDuring the follow-up period, HF occurred in 19960 patientsIn patients without HF after 5 years of T2D diagnosis, patients without IHD and ESRD had the lowest five-year risk of HF ( 4.02%; 95% confidence interval (CI) of 3.90-4.15), combined IHD (11.51%; relative risk (RR) was 2.86; 95% CI was 2.72-3.02; P 0.001) or ESRD (8.11%; RR is 2.02; 95% confidence interval is 1.39-2.93; Patients with P2D with a moderate risk, combined with IHD and ESRD patients (19.76%; RR is 4.92; 95% CI is 3.43-7.05; P 0.001) the highest riskthus, patients with combined IHD, ESRD, or both have a higher risk of HF than patients with combined IHD and ESRDPrevention of IHD and ESRD may be an effective means of delaying or preventing the occurrence of HF in T2D patients